Related Experiment Video
Updated: Jan 29, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Aspirin in childhood acute ischemic stroke: The evidence for treatment and efficacy testing
Alexander A Boucher1,2, J Michael Taylor2,3, Lori Luchtman-Jones1,2
1Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital, Cincinnati, Ohio.
Insights
Aspirin is widely used for childhood stroke, but optimal use and efficacy in pediatric patients remain unclear. Further research and monitoring are crucial for effective aspirin therapy in children with acute ischemic stroke.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Cardiovascular Research
Background:
- Aspirin is a common antiplatelet medication globally.
- Its use in pediatric acute ischemic stroke lacks robust evidence.
- Significant knowledge gaps exist regarding optimal pediatric aspirin protocols.
Purpose of the Study:
- To review the evidence for aspirin in childhood acute ischemic stroke.
- To summarize aspirin pharmacology and factors affecting its efficacy.
- To discuss laboratory monitoring of aspirin effectiveness in children.
Main Methods:
- Literature review of existing studies on aspirin in pediatric stroke.
- Pharmacological analysis of aspirin's mechanism and metabolism.
- Discussion of clinical scenarios and monitoring techniques.
Main Results:
- Evidence for aspirin's efficacy in pediatric stroke is variable and limited.
- Understanding aspirin pharmacology can clarify misconceptions and improve clinical application.
- Laboratory monitoring may play a role in optimizing aspirin therapy.
Conclusions:
- High-quality clinical trials are needed to establish optimal pediatric aspirin use.
- Addressing knowledge gaps in pediatric stroke management is essential.
- Pharmacological understanding and monitoring can enhance aspirin's role in children.
Abstract:
Aspirin is the most commonly prescribed antiplatelet agent worldwide, but evidence supporting its use varies by age and disease process. Despite its frequent use in childhood acute ischemic stroke prevention and management, major knowledge gaps exist about optimal pediatric aspirin use, particularly in this setting, where high-quality clinical trials are urgently needed. This review focuses upon the evidence for aspirin use in childhood acute ischemic stroke, includes a summary of aspirin pharmacology to highlight misconceptions and common clinical situations which may limit its efficacy, and discusses the techniques and potential role of laboratory monitoring of aspirin efficacy in children.
Related Concept Videos
The Evidence for Evolution
Self-Efficacy
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

